Clin2
NCT05859659Possibly a fitRecruiting

Hope HOPE study for glioma using pathology and MRI

Brain (Nervous System) CancersGliomaBrain Tumor

Part of Brain & nervous system, Cancer clinical trials.

This study looks at glioma (a type of brain tumor) and uses brain tissue testing, MRI scans, and related measurements to better understand the disease. You may benefit by being closely assessed with MRI and study follow-up, though it’s not necessarily testing a new medicine based on the listed criteria.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
70,000 people
Ages
18 years to 90 years
Study type
Observational

Who can take part

  • You have a confirmed diagnosis of glioma from pathology (tissue testing).
  • You can have a complete brain MRI scan with clear images.
  • You are willing to sign informed consent to join the study.
  • You do not have another neurological condition that could interfere with results.
  • You have not had brain surgery/biopsy, radiation, or chemotherapy before joining.
  • You can do study check-ins, required tests, and follow-up, and you can tolerate an MRI (with images without major motion/artifacts).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05386043Recruiting
Study brain tumor testing with MRI and extra tissue samples

This study looks at how brain tumors look on MRI and what biopsy tissue shows, using samples taken during planned surgery. It may help improve understanding of tumor biology and future treatment planning.

Indianapolis, Indiana
NCT05700071Recruiting
MRI study of brain tumor genetics

This trial uses a special MRI scan to study the genetics of gliomas (a type of brain tumor). It may help doctors better understand your tumor and choose the right treatment. You can join if you have a suspected or confirmed low- or high-grade glioma that still has a measurable tumor after surgery.

Paris
NCT03526822Recruiting
Study of new glioblastoma using MRI scans and lab markers

This study follows people newly diagnosed with glioblastoma to see how certain lab signals (MMP2 and MMP9) match up with MRI scan features. It may help doctors better understand the disease and how it appears on imaging, but it’s mainly observational.

Marseille
NCT03739411Recruiting· Phase 1
MRI scan with a special agent to assess brain tumors

This Phase 1 study tests a new type of MRI scan using a special “hyperpolarized” imaging agent to help doctors diagnose glioma (a type of brain tumor). It’s mainly focused on whether the scan can safely and clearly show tumor-related information in people who may need treatment.

San Francisco, California
NCT05259605Recruiting
Study uses brain tumor tissue and scans to track treatment outcomes

This is an observational study that collects and compares information from patients with primary brain tumors and their treatment results. It uses stored tumor tissue and brain scans to better understand outcomes using updated tumor classification methods.

Innsbruck
NCT05140785Not yet recruiting
Using MRI scans to study brain tumor activity markers

This study looks at MRI scans to find “molecular markers” that may reflect how active a brain tumor is. If you’re having surgery for a primary brain tumor, these scan results may help researchers better understand tumor behavior.

London

Hear when a new Brain (Nervous System) Cancers trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.